This file is part of IDEAS, which uses RePEc data


[ Papers | Articles | Software | Books | Chapters | Authors | Institutions | JEL Classification | NEP reports | Search | New papers by email | Author registration | Rankings | Volunteers | FAQ | Blog | Help! ]

Psychiatric Drug Use Among Patients of a Community Mental Health Service: Patterns and Implications

Author info | Abstract | Publisher info | Download info | Related research | Statistics
Author Info
Natasa Gisev (Faculty of Pharmacy, University of Sydney, Sydney, New South Wales, Australia)
J. Simon Bell (Faculty of Pharmacy, University of Sydney, Sydney, New South Wales, Australia)
Andrew J. McLachlan (Faculty of Pharmacy, University of Sydney, Sydney, New South Wales, Australia)
Manoranjenni Chetty (Faculty of Pharmacy, University of Sydney, Sydney, New South Wales, Australia)
Timothy F. Chen (Faculty of Pharmacy, University of Sydney, Sydney, New South Wales, Australia)
Abstract

Background and objective: Patients of community mental health services frequently self-report experiencing adverse drug reactions (ADRs). The objective of this study was to assess and discuss the pattern of psychiatric drug use observed among patients of a community mental health service in Sydney, Australia. Methods: This descriptive study was conducted from July 2005 to March 2006. Trained pharmacists conducted semi-structured interviews (30-45 minutes each) with 56 patients receiving psychiatric drugs and community-based case management for a long-term or persistent bipolar mood disorder or psychotic illness. The pharmacists reviewed drug charts, obtained community pharmacy dispensing records, and contacted other healthcare providers to compile a complete drug use record for each patient. These included prescription, non-prescription, and complementary and alternative medicines (CAMs). Patients' drug use records were analyzed using eight psychiatric drug use indicators: (i) high dose antipsychotics; (ii) antipsychotic polypharmacy; (iii) atypical polypharmacy; (iv) multiple `when required' drugs; (v) sub-therapeutic doses of mood stabilizers; (vi) hypnotic prescribing; (vii) psychiatric therapeutic duplication (same therapeutic class); and (viii) >=3 psychiatric drugs. Drug use records were also screened for `potentially significant' drug-drug interactions using the Thomson Micromedex Drug-Reax(R) System. Results: The mean number of items (prescription drugs, non-prescription drugs, and CAMs) taken by each patient interviewed by the pharmacists was 7.80_+-_4.66. This included 2.91_+-_1.31 different psychiatric drugs by generic name, 0.86_+-_1.71 CAMs, and 1.00_+-_1.53 other non-prescription drugs. Twenty-eight patients (50%) were taking >=2 psychiatric drugs from the same therapeutic class, and 23 (41%) were prescribed >=2 antipsychotic drugs concurrently. Twenty-six patients (46%) were prescribed >=1 antipsychotic drug at a dose exceeding that recommended in treatment guidelines. Potential drug-drug interactions were identified for 37 (66%) of the patients interviewed, with one or more potentially major drug-drug interactions being identified for 24 patients (43%). Conclusions: Psychiatric drugs were frequently used in combinations and doses outside those recommended in treatment guidelines. This highlights the importance of developing strategies to prevent and detect ADRs. Hence, regular and routine reviews of all drugs prescribed for patients of community mental health services may be warranted to minimize the risk of serious ADRs or drug-drug interactions.

Download Info
To download:

If you experience problems downloading a file, check if you have the proper application to view it first. Information about this may be contained in the File-Format links below. In case of further problems read the IDEAS help file. Note that these files are not on the IDEAS site. Please be patient as the files may be large.

File URL: http://diseasemanagement.adisonline.com/pt/re/dmo/pdfhandler.00115677-200614060-00006.pdf
File Format: application/pdf
File Function:
Download Restriction: Pay per view
File URL: http://diseasemanagement.adisonline.com/pt/re/dmo/fulltext.00115677-200614060-00006.htm
File Format: text/html
File Function:
Download Restriction: Pay per view

As the access to this document is restricted, you may want to look for a different version under "Related research" (further below) or search for a different version of it.

Publisher Info
Article provided by Wolters Kluwer Health | Adis in its journal Disease Management & Health Outcomes.

Volume (Year): 14 (2006)
Issue (Month): 6 ()
Pages: 369-376
Download reference. The following formats are available: HTML, plain text, BibTeX, RIS (EndNote), ReDIF
Handle: RePEc:wkh:dmhout:v:14:y:2006:i:6:p:369-376

Contact details of provider:
Web page: http://diseasemanagement.adisonline.com/

For technical questions regarding this item, or to correct its listing, contact: (Remco Bouckaert).

Related research
Keywords: Antipsychotics Drug-utilisation Psychiatric-disorders

Find related papers by JEL classification:
C - Mathematical and Quantitative Methods
D - Microeconomics
I - Health, Education, and Welfare
Z - Other Special Topics
I1 - Health, Education, and Welfare - - Health
I19 - Health, Education, and Welfare - - Health - - - Other
I18 - Health, Education, and Welfare - - Health - - - Government Policy; Regulation; Public Health
I11 - Health, Education, and Welfare - - Health - - - Analysis of Health Care Markets

Statistics
Access and download statistics

Did you know? You can include your works in the database easily by uploading them on the Munich Personal RePEc Archive (MPRA) if you do not have access to an institutional RePEc archive.

This page was last updated on 2008-12-29.


This information is provided to you by IDEAS at the Department of Economics, College of Liberal Arts and Sciences, University of Connecticut using RePEc data on a server sponsored by the Society for Economic Dynamics.